+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-04-11Number of Pages: 212

Mycoplasma Diagnostics Market (Products - Kits & Reagents, Instruments, and Software & Services; Technologies - PCR, Immunoassay (ELISA, RIA), DNA Staining, and Microbial Culture Techniques; End Users - Hospitals, Diagnostic Laboratories, and Clinics) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Global Mycoplasma Diagnostics Market: Snapshot

Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry.  Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests. But decline in cost per sample analysis and labor cost, improvements in automation and introduction of advanced technologies has extended the usage of molecular diagnostics in wide range of applications. The market for mycoplasma diagnostics has expanded since 1990’s with the introduction of PCR. It is estimated that in the U.S. over 600 laboratories and 200 independent laboratories perform mycoplasma diagnostics test to simplify and accelerate the testing process.

The global mycoplasma diagnostics market, which stood at US$602.0 mn in 2016, is forecast to reach US$1.35 bn by the end of 2024. If these figures hold true, the market will exhibit a CAGR of 10.6% between 2016 and 2024.

mycoplasma diagnostics market

Demand for Software & Services Projected to Increase at High Pace

Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.

By technology, PCR, immunoassay, DNA staining, microbial culture techniques and others are the key market segments. Currently, the PCR segment contributes the largest share in the revenue generated by the market based on technology. The demand for PCR is forecast to increase considerably in the coming years owing to the rising incidence of hospital acquired infections. The diagnostic technology provides rapid turnaround time, reduction in cost of sequencing, and sensitivity. As end users get to know benefits offered by PCR, the demand from the segment will increase in response.

By end users, global mycoplasma diagnostic market is dominated by hospitals & diagnostic laboratories. Hospitals & diagnostic laboratories are an important channel for the usage of multiplexed diagnostic products & offer a range of diagnosis solutions. They are an important channel for the usage of multiplexed diagnostic products. According to the norms of government health care facilities, they offer reimbursement plans and advanced technology systems for treatment.

North America Holds Dominance, But Asia Pacific to Report Higher CAGR

Regionally, North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa constitute the key market segments. Among these regions, North America held dominance in 2016 with an estimated share of 35.4% in the overall market. Several large research laboratories are present in North America. Besides this, the region also boasts a high level of public awareness, which provides an environment conducive to the growth of the mycoplasma diagnostics market. Furthermore, in the coming years, the market is expected to gain from the increasing demand for point of care testing.

Despite dominance exercised by the North America market, during the forecast period Asia Pacific will showcase more lucrative opportunities. Besides the high incidence of respiratory tract infection witnessed in the last few years, the emerging nations in the region boasts high healthcare spending, which has helped the mycoplasma market exhibit strong growth in Asia Pacific. In addition, the regional market is forecast to gain from the rising demand for personalized medicines, rise in research and development investments, and the rising public awareness.

Key players operating in this market include F. Hoffmann-La Roche Ltd., Agilent Technologies, Sartorius Stedim BioOutsource Limited, Savyon Diagnostics, Takara Bio Inc. (Takara Holding Company Inc.), Lonza Group, Merck KGaA, and Charles River Laboratories International, Inc. among others.

1 Preface
    1.1 Report Scope
    1.2 Market Segmentation 
    1.3 Research Highlights

2 Assumptions and Research Methodology
    2.1 Assumptions    
    2.2 Acronyms Used
    2.3 Research Methodology

3 Executive Summary

4 Market Overview
    4.1 Global Mycoplasma Diagnostic Market Snapshot
    4.2 Key Industry Events
    4.3 Market Indicators

5 Market Dynamics
    5.1 Drivers and Restraints Snapshot Analysis
    5.2 Drivers
    5.3 Restraints
    5.4 Opportunity Analysis 
    5.5 Opportunities
    5.6 Porter’s Five Forces Analysis
    5.7 Value Chain Analysis 
    5.8 Global Mycoplasma Diagnostics Market Analysis and Forecast (US$ Mn), 2014–2024
    5.9 Global Mycoplasma Diagnostics Market Market Outlook 
    5.10 Patents & Product Launch Analysis in Diagnostics 
    5.11 Advantages, Disadvantages, & the Availability of Select Mycoplasma Diagnostic Methods
    5.12 Product Distribution Strategies 

6 Global Mycoplasma Diagnostics Market Analysis, by Product Type    
    6.1 Key Findings 
    6.2 Introduction
    6.3 Global Mycoplasma Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2024
    6.4 Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
    6.5 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2015–2024
    6.6 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Instruments, 2015–2024
    6.7 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Software & Services, 2015–2024
    6.8 Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Product Type
    6.9 Key Trends

7 Global Mycoplasma Diagnostics Market Analysis By Technology
    7.1 Key Findings
    7.2 Introduction
    7.3 Global Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
    7.4 Global Mycoplasma Diagnostics Market Value Share Analysis, by Immunoassay, 2016 and 2024
    7.5 Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2024
    7.6 Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology (Immunoassay), 2015–2024
    7.7 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by PCR, 2014–2024
    7.8 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay, 2014–2024
    7.9 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DNA Staining, 2014–2024
    7.10 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microbial Culture Technique, 2014–2024
    7.11 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2014–2024
    7.12 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay - ELISA, 2014–2024
    7.13 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay - RIA, 2014–2024
    7.14 Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology
    7.15 Key Trends

8 Global Mycoplasma Diagnostics Market Analysis, by End-user
    8.1 Key Findings
    8.2 Introduction
    8.3 Global Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
    8.4 Global Mycoplasma Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by End-user, 2014–2024
    8.5 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Hospitals)
    8.6 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Diagnostic Laboratories)
    8.7 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Clinics)
    8.8 Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user
    8.9 Key Trends

9 Global Mycoplasma Diagnostics Market Analysis By Region
    9.1 Global Regulatory Scenario
    9.2 Global Mycoplasma Diagnostics Market Value Share Analysis By Region Type, 2016 and 2024
    9.3 Global Mycoplasma Diagnostics Market Size (US$ Mn)) Forecast, By Region Type, 2014–2024
    9.4 Global Mycoplasma Diagnostics Market Attractiveness Analysis, By Region Type

10 North America Mycoplasma Diagnostics Market Analysis
    10.1 Key Findings
    10.2 North America Mycoplasma Diagnostics Market Overview
    10.3 North America Market Value Share Analysis By Country, 2016 and 2024
    10.4 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
    10.5 North America Market Value Share Analysis By Product Type, 2016 and 2024
    10.6 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
    10.7 North America Market Value Share Analysis By Technology , 2016 and 2024
    10.8 North America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    10.9 North America Market Value Share Analysis By Technology , 2016 and 2024
    10.10 North America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    10.11 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology 
    10.12 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology , 2014–2024
    10.13 North America Mycoplasma Diagnostics Market Value Share Analysis By End Users , 2016 and 2024
    10.14 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User , 2015–2024
    10.15 North America Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
    10.16 North America Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
    10.17 North America Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

11 Europe Mycoplasma Diagnostics Market Analysis
    11.1 Key Findings
    11.2 Europe Mycoplasma Diagnostics Market Overview
    11.3 Europe Market Value Share Analysis By Country, 2016 and 2024
    11.4 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
    11.5 Europe Market Value Share Analysis By Product Type, 2016 and 2024
    11.6 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
    11.7 Europe Market Value Share Analysis By Technology , 2016 and 2024
    11.8 Europe Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    11.9 Europe Market Value Share Analysis By Technology , 2016 and 2024
    11.10 Europe Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    11.11 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology 
    11.12 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology , 2014–2024
    11.13 Europe Mycoplasma Diagnostics Market Value Share Analysis By End Users,  2016 and 2024
    11.14 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024
    11.15 Europe Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
    11.16 Europe Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
    11.17 Europe Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

12 Asia Pacific  Mycoplasma Diagnostics Market Analysis
    12.1 Key Findings
    12.2 Asia Pacific  Mycoplasma Diagnostics Market Overview
    12.3 Asia Pacific  Market Value Share Analysis By Country, 2016 and 2024
    12.4 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
    12.5 Asia Pacific  Market Value Share Analysis By Product Type, 2016 and 2024
    12.6 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
    12.7 Asia Pacific  Market Value Share Analysis By Technology , 2016 and 2024
    12.8 Asia Pacific  Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    12.9 Asia Pacific  Market Value Share Analysis By Technology , 2016 and 2024
    12.10 Asia Pacific  Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    12.11 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology 
    12.12 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology , 2014–2024
    12.13 Asia Pacific  Mycoplasma Diagnostics Market Value Share Analysis By End Users , 2016 and 2024
    12.14 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User , 2015–2024
    12.15 Asia Pacific  Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
    12.16 Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
    12.17 Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

13 Latin America Mycoplasma Diagnostics Market Analysis
    13.1 Key Findings
    13.2 Latin America Mycoplasma Diagnostics Market Overview
    13.3 Latin America Market Value Share Analysis By Country, 2016 and 2024
    13.4 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
    13.5 Latin America Market Value Share Analysis By Product Type, 2016 and 2024
    13.6 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
    13.7 Latin America Market Value Share Analysis By Technology , 2016 and 2024
    13.8 Latin America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    13.9 Latin America Market Value Share Analysis By Technology , 2016 and 2024
    13.10 Latin America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    13.11 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology 
    13.12 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology , 2014–2024
    13.13 Latin America Mycoplasma Diagnostics Market Value Share Analysis By End Users , 2016 and 2024
    13.14 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User , 2015–2024    
    13.15 Latin America Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
    13.16 Lain America Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
    13.17 Latin America Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

14 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Analysis
    14.1 Key Findings
    14.2 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Overview
    14.3 Middle East & Africa (MEA) Market Value Share Analysis By Country, 2016 and 2024
    14.4 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
    14.5 Middle East & Africa (MEA) Market Value Share Analysis By Product Type, 2016 and 2024
    14.6 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
    14.7 Middle East & Africa (MEA) Market Value Share Analysis By Technology, 2016 and 2024    
    14.8 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
    14.9 Middle East & Africa (MEA) Market Value Share Analysis By Technology, 2016 and 2024
    14.10 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
    14.11 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology 
    14.12 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2014–2024
    14.13 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Value Share Analysis By End Users, 2016 and 2024
    14.14 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024
    14.15 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
    14.16 Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
    14.17 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

15 Competition Landscape
    15.1 Global Mycoplasma Diagnostics Market Share Analysis, by Company, 2016 
    15.2 Competition Matrix

16 Company Profiles
    16.1 Agilent Technologies, Inc 
           16.1.1 Company Overview
           16.1.2 Business Overview
           16.1.3 Financial Overview
           16.1.4 SWOT Analysis
           16.1.5 Strategic Overview
    16.2 Thermo Fisher Scientific Inc 
           16.2.1 Company Overview
           16.2.2 Business Overview
           16.2.3 Financial Overview
           16.2.4 SWOT Analysis
           16.2.5 Strategic Overview
    16.3 PromoCell GmbH 
           16.3.1 Company Overview
           16.3.2 Business Overview
           16.3.3 Financial Overview
           16.3.4 SWOT Analysis
           16.3.5 Strategic Overview
    16.4 Charles River Laboratories International, Inc 
           16.4.1 Company Overview
           16.4.2 Business Overview
           16.4.3 Financial Overview
           16.4.4 SWOT Analysis
           16.4.5 Strategic Overview
    16.5 Merck KGaA 
           16.5.1 Company Overview
           16.5.2 Business Overview
           16.5.3 Financial Overview
           16.5.4 SWOT Analysis
           16.5.5 Strategic Overview
    16.6 Lonza Group 
           16.6.1 Company Overview
           16.6.2 Business Overview
           16.6.3 Financial Overview
           16.6.4 SWOT Analysis
           16.6.5 Strategic Overview
    16.7 Takara Bio Inc (Takara Holding Company Inc.)
           16.7.1 Company Overview
           16.7.2 Business Overview
           16.7.3 Financial Overview
           16.7.4 SWOT Analysis
           16.7.5 Strategic Overview
    16.8 Savyon Diagnostics
           16.8.1 Company Overview
           16.8.2 Business Overview
           16.8.3 Financial Overview
           16.8.4 SWOT Analysis
           16.8.5 Strategic Overview
    16.9 Tecan Trading AG (Tecan Group) 
           16.9.1 Company Overview
           16.9.2 Business Overview
           16.9.3 Financial Overview
           16.9.4 SWOT Analysis
           16.9.5 Strategic Overview
    16.10 Sartorius Stedim BioOutsource Limited 
           16.10.1 Company Overview
           16.10.2 Business Overview
           16.10.3 Financial Overview
           16.10.4 SWOT Analysis
           16.10.5 Strategic Overview
    16.11 American Type Culture Collection (ATCC) 
           16.11.1 Company Overview
           16.11.2 Business Overview
           16.11.3 Financial Overview
           16.11.4 SWOT Analysis
           16.11.5 Strategic Overview
    16.12 F Hoffmann-La Roche Ltd 
           16.12.1 Company Overview
           16.12.2 Business Overview
           16.12.3 Financial Overview
           16.12.4 SWOT Analysis
           16.12.5 Strategic Overview

List of Figures 

Figure 1: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2014–2024
Figure 2: Global Mycoplasma Diagnostics Market Value Share, by Product Type (2016)
Figure 3: Global Mycoplasma Diagnostics Market Value Share, by technology (2016) 
Figure 4: Global Mycoplasma Diagnostics Market Value Share, by Region (2016)
Figure 5: Global Mycoplasma Diagnostics Market Value Share, by End-user (2016) 
Figure 06: Global Mycoplasma Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 07: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2015–2024
Figure 08: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Instruments, 2015–2024
Figure 09: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Software & Services, 2015–2024
Figure 10: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Product Type
Figure 11: Global Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
Figure 12: Global Mycoplasma Diagnostics Market Value Share Analysis, by Immunoassay, 2016 and 2024
Figure 13: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by PCR, 2014–2024
Figure 14: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay, 2014–2024
Figure 15: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DNA Staining, 2014–2024
Figure 16: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microbial Culture Technique, 2014–2024
Figure 17: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2014–2024
Figure 18: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay - ELISA, 2014–2024
Figure 19: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay - RIA, 2014–2024
Figure 20: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology
Figure 21: Global Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
Figure 22: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Hospitals)
Figure 23: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Diagnostic Laboratories)
Figure 24: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Clinics)
Figure 25: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (By Others)
Figure 26: Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user
Figure 27: Global Mycoplasma Diagnostics Market Value Share Analysis, by Region, 2016 and 2024
Figure 28: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Region
Figure 29: North America Market Size (US$ Mn) Forecast, 2015–2024
Figure 30: North America Market Size Y-o-Y Growth Projections, 2015–2024
Figure 31: North America Market Value Share Analysis By Country, 2016 and 2024
Figure 32: North America Market Value Share Analysis By Product Type, 2016 and 2024
Figure 33: North America Market Value Share Analysis By Technology, 2016 and 2024
Figure 34: North America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
Figure 35: North America Mycoplasma Diagnostics Market Value Share Analysis By End Users, 2016 and 2024
Figure 36: North America Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type 
Figure 37: North America Market Attractiveness Analysis By Technology
Figure 38: North America Market Attractiveness Analysis By End Users
Figure 39: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2015–2024
Figure 40: Europe Mycoplasma Diagnostics Market attractiveness by country.
Figure 41: Europe Market Value Share Analysis By Country, 2016 and 2024
Figure 42: Europe Market Value Share Analysis By Product Type, 2016 and 2024
Figure 43: Europe Market Value Share Analysis By Technology, 2016 and 2024
Figure 44: Europe Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
Figure 45: Europe Market Value Share Analysis By End Users, 2016 and 2024
Figure 46: Europe Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type 
Figure 47: Europe Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
Figure 48: Europe Mycoplasma Diagnostics Market Attractiveness Analysis By End Users
Figure 49: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2015–2024
Figure 50: Asia Pacific Market Attractiveness Analysis By Country
Figure 51: Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
Figure 52: Asia Pacific Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 53: Asia Pacific Market Value Share Analysis, by Technology, 2016 and 2024
Figure 54: Asia Pacific Mycoplasma Diagnostics Market Value Share Analysis, by Immunoassay, 2016 and 2024
Figure 55: Asia Pacific Market Value Share Analysis, by End-user, 2016 and 2024
Figure 56: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by Product Type
Figure 57: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology
Figure 58: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user
Figure 59: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2015–2024
Figure 60: Latin America Market attractiveness by country, 2015–2024
Figure 61: Latin America Market Value Share Analysis By Country, 2016 and 2024
Figure 62: Latin America Market Value Share Analysis By Product Type, 2016 and 2024
Figure 63: Latin America Market Value Share Analysis By Technology, 2016 and 2024
Figure 64: Latin America Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
Figure 65: Latin America Market Value Share Analysis By End Users, 2016 and 2024
Figure 66: Latin America Market Attractiveness Analysis By Product Type 
Figure 67: Latin America Market Attractiveness Analysis By Technology
Figure 68: Latin America Market Attractiveness Analysis By End Users
Figure 69: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2015–2024
Figure 70: Middle East & Africa Mycoplasma Diagnostics Market Size Y-o-Y Growth Projections, 2015–2024
Figure 71: Middle East & Africa Market Value Share Analysis By Country, 2016 and 2024
Figure 72: Middle East & Africa Market Value Share Analysis By Product Type, 2016 and 2024
Figure 73: Middle East & Africa Market Value Share Analysis, by Technology, 2016 and 2024
Figure 74: Middle East & Africa Market Value Share Analysis, by Immunoassay, 2016 and 2024
Figure 75: Middle East & Africa Mycoplasma Diagnostics Market Value Share Analysis By End Users, 2016 and 2024
Figure 76: Middle East & Africa Market Attractiveness Analysis By Product Type 
Figure 77: Middle East & Africa Market Attractiveness Analysis By Technology
Figure 78: Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis By End Users
Figure 79: Global Market Share Analysis, by Company, 2016 (Estimated)

List of Tables 

Table 01: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 02: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2024
Table 03: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2024
Table 04: Global Mycoplasma Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by End-user, 2015–2024
Table 05: Global Mycoplasma Diagnostics Market Size (US$ Mn)) Forecast, by Region, 2014–2024
Table 06: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
Table 07: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
Table 08: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 09: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 10: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 11: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2014–2024
Table 12: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
Table 13: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2014–2024
Table 14: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 15: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 16: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 17: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 18: Asia Pacific Market Size (US$ Mn) Forecast, by Technology, 2014–2024
Table 19: Asia Pacific Market Size (US$ Mn) Forecast, by Immunoassay, 2015–2024
Table 20: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2024
Table 21: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, By Country, 2014–2024
Table 22: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
Table 23: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2014–2024
Table 24: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 25: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2014–2024
Table 26: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2014–2024
Table 27: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2014–2024
Table 28: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2014–2024
Table 29: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 30: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024

Global Mycoplasma Diagnostics Market: Overview

This report on mycoplasma diagnostics studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various mycoplasma techniques and products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global mycoplasma diagnostics market with respect to the leading market segments based on major products, key techniques, end-users, and geographies.

Global Mycoplasma Diagnostics Market: Scope of the Report

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global mycoplasma diagnostic market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products/techniques /end-users/geographies. The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the report. The section also includes completion matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Global Mycoplasma Diagnostics Market: Key Segments

The global mycoplasma diagnostics market has been studied based on major product segments, technique segment, their end-users, and regional as well as national markets. Based on product type, the global market has been categorized into three major 4 segments: Kits & reagents, instruments, software’s & services. On the basis of technology the mycoplasma diagnostics market are classified as PCR (Polymerase Chain Reaction), Immunoassay (ELISA, RIA), DNA staining, Microbial Culture Techniques, Others. On the basis of end users the market has been classified as hospitals, diagnostic laboratories, clinics and others.

The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year.

Global Mycoplasma Diagnostics Market: Regional Outlook

Geographically, the mycoplasma diagnostic market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for microfluidics has been further categorized into major product, technology, and end-user segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year.

Companies Mentioned in the Report

The report also profiles key players operating in the microfluidics market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Agilent Technologies, Sartorius Stedim BioOutsource Limited, Savyon Diagnostics, Takara Bio Inc. (Takara Holding Company Inc.), Lonza Group, Merck KGaA, and Charles River Laboratories International, Inc. among others.

The global mycoplasma diagnostics market is segmented as follows:

Mycoplasma Diagnostics Market, by Product

  • Kits & Reagents
  • Instruments
  • Software & Services

Mycoplasma Diagnostics Market, by Technology

  • PCR
  • Immunoassay
    • ELISA
    • RIA
  • DNA staining
  • Microbial Culture Techniques
  • Others

Mycoplasma Diagnostics Market, by End Users

  • Hospitals
  • Diagnostic Laboratories
  • Clinics
  • Others

Global Multiplexed Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa


 
 
Back To Top